Chief Business Officer at Massachusetts Biotechnology Council
President, OPEN New England
Imran Nasrullah has more than 15 years experience biotechnology. Imran has spent over 12 years in BD&L in both corporate and academic spheres. Imran brings this experience to the MBC as Chief Business Officer of the MBC.
Prior to the MBC, Imran worked for Genzyme Corporation, Millennium Pharmaceuticals, Dana Farber Cancer Institute and the Mayo Clinic; all in the business development and licensing capacity.
Imran's experience extends to having negotiated in-license and out-licenses in therapeutics, diagnostics, and technology platforms; as well as negotiated and executed complex and varied agreements with biopharmaceutical, academic, and government entities thereby enhancing R&D activities, acquiring strategic assets, accelerating product and service launches. In his BD&L role Imran led teams charged with identifying, evaluating, and pursuing all stages of technology, early stage NCEs, NMEs, and diagnostic tests for acquisition, launch and out-license.
Imran possesses proven leadership, scientific acumen, legal and financial savvy, skillful negotiations, and articulate communications skills. Imran leverages critical thinking, adept negotiations and sophisticated quantitative tools to compare business and technology opportunities, structure and negotiate business deals, analyze intellectual property and financial exposure for drug development programs, technology platforms and new diagnostic services.
Imran has his Master's of Science degree from the University of Colorado, Boulder, in exercise biochemistry, and his Juris Doctor, from Suffolk University Law School in Boston, MA.